These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9422126)

  • 1. Immunoglobulin high-dose therapy: RBC-alloantibodies in commercial preparations and haemolytic anaemia: a case report.
    Kluge A; Dopfer R; Pfeiffer-Wolf I; Roelcke D
    Beitr Infusionsther Transfusionsmed; 1994; 32():474-5. PubMed ID: 9422126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Massive intravascular haemolysis after high dose intravenous immunoglobulin therapy.
    Mohamed M; Bates G; Eastley B
    Br J Haematol; 2013 Mar; 160(5):570. PubMed ID: 23294261
    [No Abstract]   [Full Text] [Related]  

  • 3. Adverse reactions after high-dose intravenous immunoglobulin: incidence in 83 patients treated for idiopathic thrombocytopenic purpura (ITP) and review of the literature.
    Schiavotto C; Ruggeri M; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):35-40. PubMed ID: 8039756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Haemolytic anaemia as a complication to intravenous infusion of human immunoglobulin].
    Juel J; Markvardsen LH; Jakobsen J
    Ugeskr Laeger; 2011 Aug; 173(33):1963-4. PubMed ID: 21849136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexistence of autoantibodies and alloantibodies to red blood cells due to blood transfusion.
    Ahrens N; Pruss A; Kähne A; Kiesewetter H; Salama A
    Transfusion; 2007 May; 47(5):813-6. PubMed ID: 17465945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose intravenous immunoglobulin repertoire versus anti-D. Disproportions in quantity and quality.
    Rewald E; Francischetti MM; Barberis L
    Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):265-9. PubMed ID: 12030430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe thrombocytopenia and haemolytic anaemia associated with ciprofloxacin: a case report with fatal outcome.
    Tuccori M; Guidi B; Carulli G; Blandizzi C; Del Tacca M; Di Paolo M
    Platelets; 2008 Aug; 19(5):384-7. PubMed ID: 18791946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case report of the efficacy of apheresis for refractory autoimmune thrombocytopenia in a patient with systemic lupus erythematosus associated hemolytic anemia.
    Yamaji K; Tsuda H; Hashimoto H
    Ther Apher Dial; 2004 Jun; 8(3):227-31. PubMed ID: 15154876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemolytic anaemia associated with high dose intravenous immunoglobulin therapy in a child with Guillain-Barré syndrome.
    Trifa M; Simon L; Hamza J; Bavoux F; des Roziers NB
    Arch Dis Child; 2003 Sep; 88(9):836-7. PubMed ID: 12937119
    [No Abstract]   [Full Text] [Related]  

  • 10. Cerebral infarctions after intravenous immunoglobulin therapy for ITP in a child.
    Lorenzana A; Armin S; Sharma A; Allarakhia I; Witkowski A
    Pediatr Neurol; 2014 Feb; 50(2):188-91. PubMed ID: 24262342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-ABO red blood cell alloantibodies following allogeneic hematopoietic stem cell transplantation.
    Franchini M; Gandini G; Aprili G
    Bone Marrow Transplant; 2004 Jun; 33(12):1169-72. PubMed ID: 15094753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoantibodies in immunoglobulin for intravenous use may cause erythrocyte sequestration.
    Shoham-Kessary H; Gershon H
    Vox Sang; 1999; 77(1):33-9. PubMed ID: 10474088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immunoglobulin in rheumatic disease.
    Klassen LW; Calabrese LH; Laxer RM
    Rheum Dis Clin North Am; 1996 Feb; 22(1):155-73. PubMed ID: 8907070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed and acute hemolytic transfusion reactions resulting from red cell antibodies and red cell-reactive HLA antibodies.
    Takeuchi C; Ohto H; Miura S; Yasuda H; Ono S; Ogata T
    Transfusion; 2005 Dec; 45(12):1925-9. PubMed ID: 16371045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Delayed haemolytic transfusion reaction due to anti-JK1 antibody].
    de Charry F; de Charry C; Gérôme P; Pavic M; Lacoin Q; Pasquet F; Debourdeau P
    Rev Med Interne; 2012 Mar; 33(3):159-61. PubMed ID: 22265095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD47 is expressed at normal levels in patients with autoimmune haemolytic anaemia and/or immune thrombocytopenia.
    Ahrens N; Pagenkopf C; Kiesewetter H; Salama A
    Transfus Med; 2006 Dec; 16(6):397-402. PubMed ID: 17163870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemolytic anemia following high-dose intravenous immunoglobulin administration.
    Tamada K; Kohga M; Masuda H; Hattori K
    Acta Paediatr Jpn; 1995 Jun; 37(3):391-3. PubMed ID: 7645396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of overt hemolytic anemia after splenectomy for thrombocytopenia in Evans syndrome with negative Coombs test].
    Nakamura Y; Arai Y; Nakamura F; Maki K; Aoyagi A; Saito K; Mitani K
    Rinsho Ketsueki; 2002 Mar; 43(3):204-6. PubMed ID: 11979754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged remission after splenectomy for refractory Evans syndrome--a case report and literature review.
    Hamidah A; Thambidorai CR; Jamal R
    Southeast Asian J Trop Med Public Health; 2005 May; 36(3):762-4. PubMed ID: 16124452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of idiopathic thrombocytopenic purpura in adults: efficacy of domestic intravenous immunoglobulin in immune thrombocytopenia].
    Pugina SA; Evdokimova NM; Rastorguev GG; Samoĭlova OS; Sorokina IV; Sidnev GV; Vasil'ev DM; Anastasiev VV; Milovidova OV; Molodovskaia EV; Borovkov NN
    Ter Arkh; 1999; 71(8):50-4. PubMed ID: 10515038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.